
11 - 50 employés
Fondée en 2019
🏥 Santé
🏭 Fabrication
🧬 Biotechnologie
💰 €75 000 000 Series D - Spyglass Pharma en 2025-06
Healthcare • Manufacturing • Biotechnology
<SpyGlass Pharma, Inc. > SpyGlass Pharma, Inc. est une entreprise en phase clinique développant le système BIM-IOL, une lentille intraoculaire à libération prolongée de médicament conçue pour administrer une thérapie contre le glaucome à action prolongée au moment de la chirurgie de la cataracte. Cette technologie intègre le traitement du glaucome à une procédure chirurgicale fiable pour combler les lacunes d'adhérence et de gestion des maladies chroniques. L'entreprise fait progresser l'appareil à travers des études précliniques et des essais cliniques (premier sur l'homme, Phase 1/2, et Phase 3).
🕒 il y a 2 mois
🇺🇸 États-Unis – Télétravail
💵 $325 000 - $385 000 / an
⏰ Temps Plein
🔴 Expert
👔 Vice-président
👻 Score fantôme 4%
🗣️🇺🇸🇬🇧 Anglais requis
D'où vient cette offre
Publiée sur la page carrières de SpyGlass Pharma, Inc. ↗, pas via un site d'emploi
Repérée par Remote Rocketship il y a 2 mois
Toujours ouverte sur le site de SpyGlass Pharma, Inc.. Vérifiée il y a 6 heures.

11 - 50 employés
Fondée en 2019
🏥 Santé
🏭 Fabrication
🧬 Biotechnologie
💰 €75 000 000 Series D - Spyglass Pharma en 2025-06
Healthcare • Manufacturing • Biotechnology
<SpyGlass Pharma, Inc. > SpyGlass Pharma, Inc. est une entreprise en phase clinique développant le système BIM-IOL, une lentille intraoculaire à libération prolongée de médicament conçue pour administrer une thérapie contre le glaucome à action prolongée au moment de la chirurgie de la cataracte. Cette technologie intègre le traitement du glaucome à une procédure chirurgicale fiable pour combler les lacunes d'adhérence et de gestion des maladies chroniques. L'entreprise fait progresser l'appareil à travers des études précliniques et des essais cliniques (premier sur l'homme, Phase 1/2, et Phase 3).
• Develop and lead the overall Medical Affairs strategy supporting late-stage clinical development, launch readiness, commercialization, and lifecycle management • Build, scale, and lead the Medical Affairs organization, including field medical and medical education capabilities • Establish objectives, processes, infrastructure, and performance expectations • Maintain an active field presence and oversee Medical Affairs activities supporting clinical trial execution • Lead investigator and site engagement, scientific exchange, and trial awareness in collaboration with Clinical Development and Clinical Operations • Lead Medical Affairs launch readiness and execution, including medical education, scientific communications, congress strategy, KOL engagement, and evidence generation • Develop and maintain strategic scientific relationships with KOLs, investigators, treatment centers, academic institutions, and external healthcare stakeholders • Lead scientific advisory boards, steering committees, investigator meetings, and other external scientific engagements • Serve as a senior medical and scientific representative for SpyGlass Pharma • Lead CME, grants, sponsorships, speaker programs, peer-to-peer education, and scientific and clinical training for field-based teams • Lead evidence generation strategy, including real-world evidence programs, post-marketing studies, investigator-initiated research, and related initiatives • Oversee scientific communications and publications, including congress abstracts, presentations, manuscripts, and other scientific content • Partner with Market Access on HEOR, value dossiers, and scientific exchange with payer and healthcare stakeholders • Lead Medical Affairs participation in medical and promotional review processes and provide medical support for regulatory interactions and product labeling activities • Ensure compliance with regulatory requirements, industry standards, company policies, and scientific exchange and medical education requirements • Partner with Commercial leadership to align medical and commercial strategies while maintaining scientific integrity and compliance • Collaborate with Clinical Development on lifecycle management, indication expansion, evidence-generation priorities, and clinical trial planning • Partner with Quality, Safety, Regulatory Affairs, and other stakeholders on post-market medical monitoring and pharmacovigilance • Gather and communicate medical insights, scientific trends, competitive intelligence, and unmet medical needs • Develop and manage Medical Affairs budgets, resource planning, and external partnerships
• Advanced scientific or clinical degree required (MD, PhD, PharmD, OD, or equivalent) • Minimum of 15 years of progressive Medical Affairs experience within the pharmaceutical or biotechnology industry, including significant leadership experience • Demonstrated experience leading Medical Affairs organizations through late-stage clinical development, pre-launch, launch, and post-launch activities • Prior ophthalmology Medical Affairs and product launch experience strongly preferred • Experience with sustained drug delivery, drug-device combination products, or related technologies preferred • Demonstrated experience building, scaling, and leading field medical and Medical Affairs organizations • Strong understanding of late-stage clinical development, clinical trial support, launch readiness, evidence generation, medical education, scientific communications, and lifecycle management • Demonstrated success developing and maintaining strategic relationships with KOLs, investigators, academic institutions, and other external scientific stakeholders • Experience developing and executing medical education, publication, evidence-generation, and scientific engagement strategies • Strong understanding of applicable FDA regulations, industry standards, compliant scientific exchange, medical education, and promotional review requirements • Excellent scientific communication and presentation skills, with the ability to translate complex clinical and scientific information for diverse audiences • Ability to travel domestically up to 50% • Ability to travel internationally, as business needs require
• Annual Bonus opportunity • Stock options • Comprehensive health, dental, and vision insurance plans • Generous paid time off, including holidays, vacation days, and personal leave • Reasonable accommodation for individuals with disabilities
Postuler MaintenantAméliorez vos chances d'obtenir un entretien en vérifiant votre score de CV avant de postuler.
🕒 il y a 2 mois
Strategy executive leading nonprofit brand and fundraising engagements at Parisleaf. Managing strategists, evolving agency methodologies, and advising partners from research through activation.
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 2 mois
VP leading government affairs, advocacy, and funding strategy for KinderCare's early childhood education organization. Representing the company with policymakers and advising executives on policy and regulatory developments.
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 2 mois
10 000+ employés
📚 Éducation
🤝 À but non lucratif
🌍 Impact social
Vice President developing rescue-mission partnerships for City Vision University, an online Christian institution serving poor and addicted individuals. Growing student referrals through outreach, fundraising, and relationship management.
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 2 mois
VP leading AECOM’s industrial environmental growth strategy, strategic accounts, and complex remediation pursuits. Driving pipeline, client relationships, and cross-practice solutions across priority industrial segments.
🇺🇸 États-Unis – Télétravail
💵 $230 000 - $285 000 / an
⏰ Temps Plein
🔴 Expert
👔 Vice-président
🦅 Parrain de Visa H1B
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 2 mois
Vice President of Growth scaling BioIntelliSense’s FDA-cleared remote patient monitoring deployments. Building commercial account management and driving healthcare customer adoption, expansion, and renewal.
🇺🇸 États-Unis – Télétravail
💵 $200 000 - $250 000 / an
💰 €45 000 000 Series B en 2021-07
⏰ Temps Plein
🔴 Expert
👔 Vice-président
🗣️🇺🇸🇬🇧 Anglais requis